Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2010 Sep 15;51(6):709-11. doi: 10.1086/655892.

Recurrence after treatment for pulmonary multidrug-resistant tuberculosis.

Author information

1
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02115, USA. mbecerra@post.harvard.edu

Abstract

We estimated the proportion of recurrence within 2 years among adults cured by individualized multidrug-resistant tuberculosis regimens in Peru. Among 310 individuals with at least 24 months of follow-up, 16 experienced an episode of recurrent tuberculosis. If we assume the worst for treatment effectiveness-that all 16 episodes were caused by the original tuberculosis strain-then 5.2% (95% confidence interval, 3.0%-8.2%) experienced true relapse. This is an upper-bound estimate of relapse on which new regimens must improve.

PMID:
20687835
DOI:
10.1086/655892
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center